Novo Nordisk (NVO) and Eli Lilly (LLY) are planning to announce new drug pricing deals with the White House, including for their blockbuster weight loss drugs, Max Bayer of Endpoints News reports.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Eli Lilly asks European nations to scrap clawback taxes, FT says
- Eli Lilly (LLY) to Build $3 Billion European Plant to Manufacture Weight-Loss Pill
- Eli Lilly’s New Study on Brenipatide: A Potential Game-Changer in Smoking Cessation
- Eli Lilly to build new $3B facility in Katwijk, the Netherlands
- Eli Lilly’s Earnings Call: Robust Growth and Strategic Wins